What's Happening?
10x Genomics has introduced Atera, a new platform designed to enhance the measurement and understanding of biology through spatial analysis. Atera offers whole-transcriptome spatial analysis with single-cell sensitivity, allowing researchers to study
gene expression, cellular states, and spatial organization within intact tissue. This platform aims to overcome previous limitations in spatial technologies, such as trade-offs between scale, sensitivity, and gene selection. Atera supports large-scale studies across various tissue types, facilitating both discovery and translational research. The platform was unveiled at the AACR Annual Meeting 2026, showcasing data from leading research institutions like the University of Pennsylvania and the German Cancer Research Institute.
Why It's Important?
The introduction of Atera marks a significant advancement in spatial biology, providing researchers with the ability to conduct comprehensive studies at an unprecedented scale. This platform is expected to transform the understanding of complex biological systems, particularly in fields like oncology, immunology, and neuroscience. By enabling detailed analysis of the tumor microenvironment and immune cell interactions, Atera could lead to new therapeutic strategies and drug development. The platform's capabilities align with the goals of the Human Cell Atlas project, which aims to map every cell type in the human body, potentially accelerating discoveries in inflammatory and fibrotic diseases.
What's Next?
10x Genomics plans to begin shipping Atera in the second half of 2026, with pre-orders already open. The platform's launch is expected to drive demand for high-throughput spatial analysis in biopharma and translational research. Global service providers like Macrogen are adopting Atera to support large-scale spatial programs. Additionally, 10x Genomics is introducing a new cloud analysis platform to facilitate data storage, analysis, and collaboration, enhancing the accessibility and impact of Atera's insights. Researchers can submit samples for whole-transcriptome spatial analysis through Catalyst Research Services, ensuring broad access to the platform.
